NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/26/2023
Back to search
Official data from USPTO
GENOVAC NANO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
GENOVAC NANO
ST13
US500000097457305Class
40, 42
Filing
97457305
Registration
7177988
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
09/26/2023
Classification
Registered
Trademark type
Word
Nice classes
40, 42
Filing date
06/14/2022
Registration date
09/26/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/26/2023
Last transaction
09/26/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
11/22/2021
First use in commerce
06/15/2022
Drawing code
4
Owner type
16
Owner location
Fargo, ND
Examiner
STURMAN, MELISSA
Law office
N70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Genovac Antibody Discovery LLC
Representatives
Thomas Kading
Technical classification
Nice Classes
Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
Biomanufacturing for othersmanufacturing of antibodiesproteinsplasmids using biological organisms in the manufacturing process
Class 42
Biotechnology research; Pharmaceutical research and development; Pharmaceutical research services; Development of new technology for others in the field of biotechnology and pharmaceuticals; Laboratory research services relating to pharmaceuticals; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the pharmaceutical and biotechnology fields; Research on the subject of pharmaceuticals; Testinginspectionresearchdevelopment of pharmaceutical preparations for gene therapy
Publications
History of USPTO decisions and trademark events.
20 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
09/26/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
08/23/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/22/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
07/18/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
07/18/2023
IUAF
USE AMENDMENT FILED
06/21/2023
EISU
TEAS STATEMENT OF USE RECEIVED
06/21/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/23/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/28/2023
PUBO
PUBLISHED FOR OPPOSITION
03/28/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/08/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/21/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
02/21/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/21/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
02/21/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/21/2023
DOCK
ASSIGNED TO EXAMINER
02/13/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/27/2022
NWAP
NEW APPLICATION ENTERED
06/17/2022
Continuous trademark protection
Get notified about every new filing that threatens GENOVAC NANO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.